Chart - Egypt - Imports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD
Chart - Egypt - Imports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD
Table - Egypt - Imports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD
Date
Export Countries
2020
2021
2022
2023
2024
United States
23.485.891
215.554.123
183.021.265
89.142.457
138.570.340
China
21.393.965
392.596.121
25.894.279
18.547.793
32.756.172
Belgium
30.493.671
172.065.609
27.918.880
48.872.964
84.631.387
Germany
42.675.837
81.204.534
62.818.989
115.736.341
56.208.329
Netherlands
11.649.061
35.480.675
60.312.837
72.804.731
104.220.136
France
40.966.599
73.425.222
49.471.347
35.787.174
38.467.180
Spain
14.552.717
21.711.721
10.182.379
28.921.862
42.051.815
Austria
6.431.773
11.805.900
14.245.015
13.335.256
10.860.184
South Korea
8.329.000
11.541.000
9.093.000
6.551.000
3.483.000
Sweden
33.513
23.232
2.631.914
7.641.242
20.634.512
Others
9.186.184
20.587.515
13.296.208
12.616.861
25.610.115
Total
209,198,211
1,035,995,653
458,886,112
449,957,682
557,493,171
Chart - Egypt - Imports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD
Chart - Egypt - Imports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD
Table - Egypt - Imports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD
Date
Export Countries
03 - 2025
04 - 2025
05 - 2025
06 - 2025
07 - 2025
United States
2.145.413
22.507.465
17.493.481
18.481.084
12.659.269
Belgium
9.164.287
7.036.946
6.602.731
41.849
8.554.110
Netherlands
7.787.168
7.298.197
1.754.385
1.855.336
7.300.564
Germany
3.408.432
3.668.149
10.826.717
3.078.196
4.155.620
China
6.930.530
3.200.957
5.184.214
2.244.173
2.583.928
Spain
2.640.073
5.026.647
2.132.611
4.035.964
80.194
France
398.613
6.982.672
627.342
1.080.784
972.718
Sweden
713.668
4.376.959
267.354
2.242.784
Austria
357.256
3.096.575
377.096
1.453.785
South Korea
360.000
798.000
682.000
194.000
417.000
Others
820.263
2.494.517
1.214.535
1.385.915
1.778.957
Total
34,725,704
62,110,125
51,272,071
34,118,441
40,745,145
Chart - Egypt - Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD
Chart - Egypt - Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD
Table - Egypt - Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD
Date
Import Countries
2020
2021
2022
2023
2024
Spain
1.463
1.523
5.130
16.313.369
51.432.525
Thailand
06
5.040.622
2.439.433
2.137.785
3.021.225
Germany
6.355
3.238
3.755
2.929
2.300.934
Malaysia
128.075
59.294
71
106.310
France
154
802
16.209
139.007
1.270
Austria
1.538
630
19.758
36.627
Italy
37.074
Belgium
148
5.825
54
5.027
1.126
Taiwan
5.000
5.000
Lithuania
13
7.249
04
Others
1.227
2.194
1.625
5.288
6.163
Total
10,890
5,187,292
2,575,454
18,623,240
56,906,179
Chart - Egypt - Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD
Chart - Egypt - Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD
Table - Egypt - Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD
Date
Import Countries
03 - 2025
04 - 2025
05 - 2025
06 - 2025
07 - 2025
Spain
5.341.644
5.025.794
8.398.998
5.378.522
8.024.520
Thailand
120.224
44.075
34.937
226.496
20.130
Bolivia
12.932
19.398
Germany
244
260
366
281
497
Portugal
186
61
193
Austria
341
Belgium
92
Netherlands
09
05
08
06
07
Ireland
36
Cyprus
06
03
06
06
06
Others
12
16
16
22
09
Total
5,462,325
5,083,085
8,453,820
5,605,431
8,045,701
Chart - Egypt - Imports - Evolution / Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD
Chart - Egypt - Imports - Evolution / Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD
Table - Egypt - Imports - Evolution / Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD
Date
Export Countries
2020
2021
2022
2023
2024
Importaciones
United States
23.485.891
215.554.123
183.021.265
89.142.457
138.570.340
China
21.393.965
392.596.121
25.894.279
18.547.793
32.756.172
Belgium
30.493.671
172.065.609
27.918.880
48.872.964
84.631.387
Germany
42.675.837
81.204.534
62.818.989
115.736.341
56.208.329
Netherlands
11.649.061
35.480.675
60.312.837
72.804.731
104.220.136
France
40.966.599
73.425.222
49.471.347
35.787.174
38.467.180
Spain
14.552.717
21.711.721
10.182.379
28.921.862
42.051.815
Austria
6.431.773
11.805.900
14.245.015
13.335.256
10.860.184
South Korea
8.329.000
11.541.000
9.093.000
6.551.000
3.483.000
Sweden
33.513
23.232
2.631.914
7.641.242
20.634.512
Others
9.186.184
20.587.515
13.296.208
12.616.861
25.610.115
Total
209,198,211
1,035,995,653
458,886,112
449,957,682
557,493,171
Date
Import Countries
2020
2021
2022
2023
2024
Exportaciones
Spain
1.463
1.523
5.130
16.313.369
51.432.525
Thailand
06
5.040.622
2.439.433
2.137.785
3.021.225
Germany
6.355
3.238
3.755
2.929
2.300.934
Malaysia
128.075
59.294
71
106.310
France
154
802
16.209
139.007
1.270
Austria
1.538
630
19.758
36.627
Italy
37.074
Belgium
148
5.825
54
5.027
1.126
Taiwan
5.000
5.000
Lithuania
13
7.249
04
Others
1.227
2.194
1.625
5.288
6.163
Total
10,890
5,187,292
2,575,454
18,623,240
56,906,179
Chart - Egypt - Imports - Evolution / Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD
Chart - Egypt - Imports - Evolution / Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD
Table - Egypt - Imports - Evolution / Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD
-and-similar-products/WD-EG/1064/1/1/Fob/DepartureCountry-Date/All-Egypt-Imports-1064-Year.png)
-and-similar-products/WD-EG/1064/1/1/Fob/DepartureCountry-Date/All-Egypt-Imports-1064-Year.png)
-and-similar-products/WD-EG/1064/1/4/Fob/DepartureCountry-Date/All-Egypt-Imports-1064-Month.png)
-and-similar-products/WD-EG/1064/1/4/Fob/DepartureCountry-Date/All-Egypt-Imports-1064-Month.png)
-and-similar-products/EG-WD/1064/2/1/Fob/DestinationCountry-Date/Egypt-All-Exports-1064-Year.png)
-and-similar-products/EG-WD/1064/2/1/Fob/DestinationCountry-Date/Egypt-All-Exports-1064-Year.png)
-and-similar-products/EG-WD/1064/2/4/Fob/DestinationCountry-Date/Egypt-All-Exports-1064-Month.png)
-and-similar-products/EG-WD/1064/2/4/Fob/DestinationCountry-Date/Egypt-All-Exports-1064-Month.png)
-and-similar-products/EG-EG/1064/3/1/Fob/-/Egypt-Import-Export-1064-Year.png)
-and-similar-products/EG-EG/1064/3/1/Fob/-/Egypt-Import-Export-1064-Year.png)
-and-similar-products/EG-EG/1064/3/4/Fob/-/Egypt-Import-Export-1064-Month.png)
-and-similar-products/EG-EG/1064/3/4/Fob/-/Egypt-Import-Export-1064-Month.png)
